TrialCardiovascular diabetology2009

Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone.

Sean D Sullivan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.